Loading...
Loading...
India's fexofenadine imports from UNITED STATES total $12.5K across 32 shipments from 13 foreign suppliers. GRANULES PHARMACEUTICALS INC leads with $6.6K in import value; the top 5 suppliers together control 88.7% of this origin. Leading Indian buyers include GRANULES INDIA LIMITED. This corridor reflects India's pharmaceutical import demand for fexofenadine — a diversified sourcing base with multiple active suppliers from UNITED STATES.

GRANULES PHARMACEUTICALS INC is the leading Fexofenadine supplier from UNITED STATES to India, with import value of $6.6K across 4 shipments. The top 5 suppliers — GRANULES PHARMACEUTICALS INC, AMSTERDAM PHARMA(APTEKA RX INC.), M/S OHM LABORATORIES , INC, AMSTERDAM PHARMA APTEKA RX INC, NEWLIFE MEDICALS (USA).INC. — collectively account for 88.7% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GRANULES PHARMACEUTICALS INC | $6.6K | 4 | 52.4% |
| 2 | AMSTERDAM PHARMA(APTEKA RX INC.) | $1.5K | 8 | 12.3% |
| 3 | M/S OHM LABORATORIES , INC | $1.1K | 1 | 8.7% |
| 4 | AMSTERDAM PHARMA APTEKA RX INC | $1.0K | 2 | 8.1% |
| 5 | NEWLIFE MEDICALS (USA).INC. | $911 | 1 | 7.3% |
| 6 | ESPEE BIOPHARMA & FINECHEM LLC | $359 | 2 | 2.9% |
| 7 | AGRACE PHARMA | $326 | 1 | 2.6% |
| 8 | NILSCH LLC | $248 | 2 | 2.0% |
| 9 | L PERRIGO COMPANY | $205 | 1 | 1.6% |
| 10 | M/S CONTRACT PHARMACAL CORP | $141 | 4 | 1.1% |
| 11 | DR REDDY S LABORATORIES LOUISIANA LLC | $98 | 2 | 0.8% |
| 12 | GRANULES USA INC | $29 | 3 | 0.2% |
| 13 | THE MASTER OF WHISTLER SPIRIT | $8 | 1 | 0.1% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | GRANULES INDIA LIMITED | $6.6K | 7 | 52.6% |
| 2 | DR.REDDY'S LABORATORIES LTD | $2.0K | 10 | 15.8% |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.1K | 1 | 8.7% |
| 4 | GLENMARK PHARMACEUTICALS LIMITED | $1.0K | 1 | 8.1% |
| 5 | SANOFI HEALTHCARE INDIA PRIVATE LIMITED | $911 | 1 | 7.3% |
| 6 | J B CHEMICALS AND PHARMACEUTICALS LIMITED | $326 | 1 | 2.6% |
| 7 | VIMTA LABS LIMITED | $205 | 1 | 1.6% |
| 8 | DR.REDDY'S LABORATORIES LIMITED | $168 | 2 | 1.3% |
| 9 | ZENRISE CLINICAL RESEARCH PRIVATE LIMITED | $141 | 4 | 1.1% |
| 10 | DR REDDYS LABORATORIES LIMITED | $99 | 3 | 0.8% |
| 11 | 3CUBE MEDICARE PRIVATE LIMITED | $8 | 1 | 0.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Fexofenadine suppliers from UNITED STATES to India include GRANULES PHARMACEUTICALS INC, AMSTERDAM PHARMA(APTEKA RX INC.), M/S OHM LABORATORIES , INC. The leading supplier is GRANULES PHARMACEUTICALS INC with import value of $6.6K USD across 4 shipments. India imported Fexofenadine worth $12.5K USD from UNITED STATES in total across 32 shipments.
India imported Fexofenadine worth $12.5K USD from UNITED STATES across 32 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Fexofenadine sourced from UNITED STATES include GRANULES INDIA LIMITED, DR.REDDY'S LABORATORIES LTD, SUN PHARMACEUTICAL INDUSTRIES LIMITED. The largest buyer is GRANULES INDIA LIMITED with $6.6K in imports across 7 shipments.
The total value of Fexofenadine imports from UNITED STATES to India is $12.5K USD, across 32 shipments and 13 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
32 Verified Shipments
13 suppliers, 11 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists